Most recent papers:

• New drug applications to Health Canada cancelled and refused: Cross-sectional study.
  Joel Lexchin.
  JRSM Short Reports. 2 days ago
  JRSM Open, Volume 17, Issue 5, May 2026.
  ObjectivesThis study looks at the number of cancellations by companies and refusals by Health Canada of new drug applications from 1 June 2019 to 1 July 2025 and the amount of information given for the decisions taken.DesignCross-sectional.SettingCanada....

  May 09, 2026   doi: 10.1177/20542704261447654   open full text
• Perioperative hormone replacement therapy (HRT) and venous thromboembolism risk: a scoping review of available evidence and guidance.
  Omar Helmy, Celine Iswarya Partha Sarathi, Diwakar Sarma.
  JRSM Short Reports. 4 days ago
  JRSM Open, Volume 17, Issue 3, March 2026.
  SummaryObjectiveHormone replacement therapy (HRT) is used to manage menopausal symptoms, but its perioperative use raises concerns about increased venous thromboembolism (VTE) risk. Clinical guidelines vary, with some advising temporary discontinuation ...

  May 07, 2026   doi: 10.1177/20542704261435338   open full text
• Erratum to "Scrotal Masson’s tumour masquerading as dysplastic polyorchidism – a case report”.
  
  JRSM Short Reports. 6 days ago
  JRSM Open, Volume 17, Issue 5, May 2026.
  

  May 05, 2026   doi: 10.1177/20542704261442225   open full text
• How should services for high-intensity users be organised? A scoping review of published literature with recommendations for future research and delivery of care.
  Peter Greengross, Ismail Ismail, Callum Parr, Rebecca Wright, Sophie Hunter.
  JRSM Short Reports. February 18, 2026
  JRSM Open, Volume 17, Issue 2, February 2026.
  AbstractObjectiveHigh Intensity Users (HIUs) of Urgent and Emergency Care (UEC) services account for disproportionately high numbers of Emergency Department (ED) attendances, ambulance journeys and non-elective admissions. This review aimed to assess the ...

  February 18, 2026   doi: 10.1177/20542704251413949   open full text